雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Biomarker study in Alzheimer's disease: What we learned from cerebrospinal fluid tau measures Hiroyuki ARAI 1 , Makoto HIGUCHI 1 , Nobuyuki OKAMURA 1 , Toshifumi MATSUI 1 , Haruko TANJI 1 , Masahiro MARUYAMA 1 , Yuichi MORIKAWA 1 , Kota ISHIZAWA 1 , Hidetada SASAKI 1 1Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine Keyword: 診断マーカー , 脳脊髄液 , タウ , アミロイドβ蛋白 pp.827-834
Published Date 2002/12/10
DOI https://doi.org/10.11477/mf.1431901433
  • Abstract
  • Look Inside

Elderly people are worried about change in their cognitive functioning. Since cholinergic therapies for Alzheimer's disease have been developed and widely accepted, elderly people come to visit clinics to seek medical advice if such a subtle change in cognitive ability may represents an early manifestation of Alzheimer's disease (AD). If they are likely to develop dementia or AD, they want to receive medical treatment as soon as possible to prevent further loss of cognitive functioning so that they can live independently as long as possible.


Copyright © 2002, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1243 印刷版ISSN 0001-8724 医学書院

関連文献

もっと見る

文献を共有